These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15467412)

  • 1. Cystic changes in intraabdominal extrahepatic metastases from gastrointestinal stromal tumors treated with imatinib.
    Kim HC; Lee JM; Choi SH; Han H; Kim SS; Lee SH; Han JK; Choi BI
    Korean J Radiol; 2004; 5(3):157-63. PubMed ID: 15467412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of computed tomography in the follow-up of hepatic and peritoneal metastases of GIST under imatinib mesylate treatment: a prospective study of 54 patients.
    Vanel D; Albiter M; Shapeero L; Le Cesne A; Bonvalot S; Le Pechoux C; Terrier P; Petrow P; Caillet H; Dromain C
    Eur J Radiol; 2005 Apr; 54(1):118-23. PubMed ID: 15797301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
    Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
    Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.
    Bechtold RE; Chen MY; Stanton CA; Savage PD; Levine EA
    Abdom Imaging; 2003; 28(6):808-14. PubMed ID: 14753595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases.
    Linton KM; Taylor MB; Radford JA
    Br J Radiol; 2006 Aug; 79(944):e40-4. PubMed ID: 16861316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.
    De Giorgi U; Aliberti C; Benea G; Conti M; Marangolo M
    Clin Cancer Res; 2005 Sep; 11(17):6171-6. PubMed ID: 16144917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
    Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors: CT and MRI findings.
    Sandrasegaran K; Rajesh A; Rushing DA; Rydberg J; Akisik FM; Henley JD
    Eur Radiol; 2005 Jul; 15(7):1407-14. PubMed ID: 15761716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).
    Chen MY; Bechtold RE; Savage PD
    AJR Am J Roentgenol; 2002 Oct; 179(4):1059-62. PubMed ID: 12239065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
    Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
    Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
    J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging characteristics of liver metastasis from gastrointestinal stromal tumor before and after imatinib mesylate treatment.
    Ulusan S; Koç Z; Kayaselçuk F
    Turk J Gastroenterol; 2008 Jun; 19(2):129-32. PubMed ID: 19110671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P; Nyckowski P; Grzesiakowska U; Nowecki ZI; Nasierowska-Guttmejer A; Pienkowski A; Dudek K; Krawczyk M; Ruka W
    Neoplasma; 2003; 50(6):438-42. PubMed ID: 14689066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography and sonographic findings of hepatic metastases from gastrointestinal stromal tumors after chemotherapy.
    Yang DM; Kim H; Kang JH; Park CH; Kim HS; Shin DB
    J Comput Assist Tomogr; 2005; 29(5):592-5. PubMed ID: 16163025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography.
    Lassau N; Lamuraglia M; Chami L; Leclère J; Bonvalot S; Terrier P; Roche A; Le Cesne A
    AJR Am J Roentgenol; 2006 Nov; 187(5):1267-73. PubMed ID: 17056915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
    Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A patient with unresectable gastrointestinal stromal tumor responded to STI571].
    Sagawa C; Koide H; Ito T; Fuchigami M; Nishiyama R; Kobayashi S; Takekawa Y; Murata A; Arakawa Y
    Nihon Shokakibyo Gakkai Zasshi; 2004 Apr; 101(4):382-8. PubMed ID: 15114834
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease progression following imatinib failure in gastrointestinal stromal tumors: role of surgical therapy.
    Jamali FR; Darwiche SS; El-Kinge N; Tawil A; Soweid AM
    Oncologist; 2007 Apr; 12(4):438-42. PubMed ID: 17470686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate induces responses in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy.
    Fiorentini G; Bernardeschi P; Rossi S; Dentico P; Biancalani M; Giustarini G; Turrisi G
    J Cancer Res Ther; 2006; 2(2):68-71. PubMed ID: 17998678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.